[1] These medicines include semaglutide (Ozempic, Wegovy, Rybelsus), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), and exenatide (Byetta, Bydureon)
Pati F, Jang J et al (2015) Extrusion bioprinting, essentials of 3D biofabrication translation
GLP-1 medications have demonstrated significant cardiovascular benefits the SELECT trial showed semaglutide reduced major cardiovascular events (heart attack, stroke, cardiovascular death) by 20% in high-risk patients
Women are affected more often than men, and people with a personal or family history of thinning are the most susceptible
After age 45, the body begins to produce less and less Glutathione and many individuals begin to support their glutathione levels through supplementation
Clinicians should also consider alternative diagnoses when evaluating muscle complaints in patients taking GLP-1 medications